We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
-4.83%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$40.5B
AUM Growth
+$7.82B
(+24%)
Cap. Flow
+$9.9B
Cap. Flow
% of AUM
24.45%
Top 10 Holdings %
Top 10 Hldgs %
11.2%
Holding
4,410
New
905
Increased
1,516
Reduced
1,218
Closed
685
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$184M |
| 2 |
Dollar General
DG
|
+$152M |
| 3 |
MongoDB
MDB
|
+$129M |
| 4 |
Starbucks
SBUX
|
+$126M |
| 5 |
Costco
COST
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$111M |
| 2 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$97.7M |
| 3 |
Automatic Data Processing
ADP
|
+$90.7M |
| 4 |
Phillips 66
PSX
|
+$82.6M |
| 5 |
CVS Health
CVS
|
+$82.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.76% |
| 2 | Consumer Discretionary | 9.1% |
| 3 | Financials | 5.7% |
| 4 | Healthcare | 5.63% |
| 5 | Industrials | 4.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRO
1451
PUT
DELISTED
Marathon Oil Corporation
MRO
| $3.29M | 0.01% |
122,900
-304,200
| -71% | -$7.87M |
|
1452
Levi Strauss
LEVI
$9.44B
| $3.29M | 0.01% |
241,989
+20,596
| +9% | +$288K |
|
1453
PUT
MetLife
MET
$61B
| $3.28M | 0.01% |
52,200
+22,700
| +77% | +$1.41M |
|
1454
CALL
Colgate-Palmolive
CL
$72.6B
| $3.28M | 0.01% |
46,100
-44,600
| -49% | -$3.33M |
|
1455
PUT
RTX Corp
RTX
$287B
| $3.27M | 0.01% |
45,400
+500
| +1% | +$42.8K |
|
1456
PUT
CRISPR Therapeutics
CRSP
$4.58B
| $3.26M | 0.01% |
71,900
-43,400
| -38% | -$2.24M |
|
|
MPT
1457
Medical Properties Trust
MPT
$2.89B
| $3.26M | 0.01% |
597,480
+513,102
| +608% | +$4.11M |
|
1458
TD Synnex
SNX
$19.4B
| $3.25M | 0.01% |
32,590
+18,127
| +125% | +$1.79M |
|
1459
AtriCure
ATRC
$1.77B
| $3.25M | 0.01% |
74,142
+39,077
| +111% | +$1.91M |
|
1460
Revolution Medicines
RVMD
$40.2B
| $3.25M | 0.01% |
117,302
+90,623
| +340% | +$2.69M |
|
1461
CALL
Dropbox
DBX
$6.81B
| $3.25M | 0.01% |
119,200
-85,200
| -42% | -$2.32M |
|
1462
PUT
Align Technology
ALGN
$12B
| $3.24M | 0.01% |
10,600
-4,000
| -27% | -$1.38M |
|
1463
Northwest Natural Holdings
NWN
$2.17B
| $3.23M | 0.01% |
84,757
+59,327
| +233% | +$2.44M |
|
1464
PUT
Edison International
EIX
$30.7B
| $3.22M | 0.01% |
50,900
-54,200
| -52% | -$3.78M |
|
|
1465
PUT
Phillips 66
PSX
$82.9B
| $3.22M | 0.01% |
26,800
+18,800
| +235% | +$2.11M |
|
1466
CALL
Universal Display
OLED
$3.71B
| $3.22M | 0.01% |
20,500
-59,000
| -74% | -$8.96M |
|
|
AZEK
1467
DELISTED
The AZEK Co
AZEK
| $3.22M | 0.01% |
108,177
-109,933
| -50% | -$3.45M |
|
1468
Charles River Laboratories
CRL
$10.9B
| $3.21M | 0.01% |
16,399
+399
| +2% | +$81.9K |
|
1469
PUT
Boot Barn
BOOT
$4.55B
| $3.21M | 0.01% |
+39,500
| New | +$3.55M |
|
1470
PUT
Las Vegas Sands
LVS
$30.5B
| $3.2M | 0.01% |
69,800
+29,300
| +72% | +$1.58M |
|
1471
IonQ
IONQ
$12.3B
| $3.2M | 0.01% |
+214,775
| New | +$3.37M |
|
1472
Neurocrine Biosciences
NBIX
$17.7B
| $3.19M | 0.01% |
28,351
-89,646
| -76% | -$9.44M |
|
1473
Nasdaq
NDAQ
$51.5B
| $3.19M | 0.01% |
65,592
-116,477
| -64% | -$5.9M |
|
1474
CALL
Xylem
XYL
$28.5B
| $3.19M | 0.01% |
+35,000
| New | +$3.61M |
|
1475
Parsons
PSN
$6.28B
| $3.19M | 0.01% |
58,613
+51,938
| +778% | +$2.75M |
|
Similar funds
Squarepoint's Q3 2023 Portfolio in Review
As of Q3 2023, Squarepoint held 4,410 positions worth $40.5B, up 24% from $32.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $9.9B of net new capital in Q3 2023, opening 905 new positions and adding to 1,516 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 840,063 shares worth $61.3M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Adobe, an estimated $111M trimmed.
- Squarepoint's largest Q3 2023 buy was State Street SPDR S&P Biotech ETF: 840,063 shares worth $61.3M.
- Squarepoint added most to Tesla in Q3 2023, an estimated $184M increase.
- Squarepoint's biggest Q3 2023 reduction was Adobe, cutting an estimated $111M.
- Squarepoint fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2023, selling an estimated $56.4M.
- Squarepoint's ten largest holdings make up 11% of its $40.5B portfolio in Q3 2023.
- Squarepoint opened 905 new positions and closed 685 in Q3 2023.
- Squarepoint's portfolio value rose 24% quarter-over-quarter to $40.5B.
Based on Squarepoint's 13F filing for Q3 2023, filed 14 Nov 2023.